| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.51 | 0.06 |